Related Experiment Video
Updated: Jun 1, 2026
08:11
Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction
Published on: August 25, 2017
Intracisternal rSV40 administration provides effective pan-CNS transgene expression
J-P Louboutin1, B A S Reyes, L Agrawal
1Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA. jplouboutin@hotmail.com
Gene Therapy
|May 27, 2011
Summary
Gene therapy using antioxidant-carrying vectors delivered to the cisterna magna (CM) achieved widespread central nervous system (CNS) expression. This approach demonstrated significant neuroprotection against HIV-1 gp120-induced damage in a rat model.
Area of Science:
- Neuroscience
- Gene Therapy
- Molecular Biology
Background:
- Generalized central nervous system (CNS) diseases often necessitate broad transgene expression for effective genetic treatment.
- Oxidative stress and apoptosis, exemplified by HIV-1 envelope gp120, are key pathological mechanisms in various CNS disorders.
- Developing methods for pan-CNS gene delivery is crucial for treating widespread neurological conditions.
Purpose of the Study:
- To investigate the efficacy of pan-CNS neuroprotective gene delivery into the cisterna magna (CM).
- To utilize recombinant simian virus 40 (rSV40) vectors carrying antioxidant enzymes (Cu/Zn superoxide dismutase or glutathione peroxidase) for gene delivery.
- To model oxidant stress and apoptosis using HIV-1 envelope gp120 in a rat system.
Main Methods:
- Recombinant SV40 vectors encoding antioxidant genes were injected into the rat CM after mannitol administration.
- Transgene expression levels and distribution throughout the CNS were monitored.
- Rats were subsequently challenged with HIV-1 gp120 in the caudate putamen to assess neuroprotection.
Main Results:
- Sustained transgene expression was observed in neurons across the entire CNS.
- Intracisternal administration of antioxidant-carrying rSV40 vectors resulted in significant neuroprotection.
- The treatment effectively countered the neurotoxic effects of gp120.
Conclusions:
- Intracisternal delivery of antioxidant-carrying rSV40 vectors enables widespread CNS transgene expression.
- This gene delivery strategy shows promise for treating CNS diseases associated with oxidative stress, such as HIV-1-associated neurocognitive disorders.
- The findings support the potential of this approach for managing widespread neurodegenerative conditions.
